WT mice immunized with MOG35-55 showed severe clinical features of MS, evidenced by significant inflammation and demyelination in spinal cords, whereas the addition of IL-27 delayed the onset of the disease, downregulated disease severity, and upregulated recovery (209). The gene discussed is IL27; the disease is myeloid sarcoma.